🕒 Saturday 23 May 2026 Sat, 23 May 2026

Battery tech, biotech and balance-sheet repair drove the biggest gains this week, while guidance cuts and weak post-halt trading hurt several names. Deal-making and fresh equity funding stayed busy, especially in rare earths, defence and gold.

Big gains in InvestSMART met heavy selling in General Capital and Klevo as investors split between clean balance-sheet stories and names carrying extra uncertainty. Finance stocks were driven by capital returns, raisings, loan growth and a handful of governance risks.

Coal, gold and critical minerals names drove the biggest share moves this week, but strong project news did not always lead to lasting gains. Several stocks jumped on funding, deals and study results, while others gave back early gains as traders locked in profit or worried about dilution.

Imugene, Vitasora and Adherium led a volatile week in healthcare shares, as trial news and software rollouts battled capital raisings, legal issues and weak sentiment in smaller biotech names. Big contracts, takeover steps and record earnings kept the sector busy, but several stocks still fell even after reporting clear operational progress.

Capital moves, contract wins and AI product pushes drove a busy week across small and mid-cap technology stocks. Hydrix, Complii and ClearVue led the board, while investors sold names where early excitement gave way to dilution concerns or softer earnings detail.